• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

经导管二尖瓣修复术：现有和未来器械概述。

Transcatheter mitral valve repair: an overview of current and future devices.

机构信息

Cardiology, Rigshospitalet, Kobenhavn, Denmark

Cardiology, Rigshospitalet, Kobenhavn, Denmark.

出版信息

Open Heart. 2021 Apr;8(1). doi: 10.1136/openhrt-2020-001564.

DOI:10.1136/openhrt-2020-001564
PMID:33911022
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8094333/
Abstract

The field of transcatheter mitral valve repair (TMVr) for mitral regurgitation (MR) is rapidly evolving. Besides the well-established transcatheter mitral edge-to-edge repair approach, there is also growing evidence for therapeutic strategies targeting the mitral annulus and mitral valve chordae. A patient-tailored approach, careful patient selection and an experienced interventional team is crucial in order to optimise procedural and clinical outcomes. With further data from ongoing clinical trials to be expected, consensus in the Heart Team is needed to address these complexities and determine the most appropriate TMVr therapy, either single or combined, for patients with severe MR.

摘要

经导管二尖瓣修复（TMVr）治疗二尖瓣反流（MR）领域正在迅速发展。除了已确立的经导管二尖瓣瓣环成形术和二尖瓣瓣叶修复术，针对二尖瓣瓣环和二尖瓣腱索的治疗策略也有了更多证据。个体化治疗方法、仔细的患者选择和经验丰富的介入团队对于优化手术和临床结果至关重要。随着即将出现更多的临床试验数据，需要心脏团队达成共识，以解决这些复杂性问题，并确定最适合严重 MR 患者的单一或联合 TMVr 治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5077/8094333/f5eb2adfed74/openhrt-2020-001564f08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5077/8094333/259f5d815fd3/openhrt-2020-001564f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5077/8094333/9543992cce8e/openhrt-2020-001564f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5077/8094333/0f4c72c38495/openhrt-2020-001564f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5077/8094333/8207ccc1fbe0/openhrt-2020-001564f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5077/8094333/0ed2c7911568/openhrt-2020-001564f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5077/8094333/ad9e229e7b7b/openhrt-2020-001564f06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5077/8094333/72ca906f1cd1/openhrt-2020-001564f07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5077/8094333/f5eb2adfed74/openhrt-2020-001564f08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5077/8094333/259f5d815fd3/openhrt-2020-001564f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5077/8094333/9543992cce8e/openhrt-2020-001564f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5077/8094333/0f4c72c38495/openhrt-2020-001564f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5077/8094333/8207ccc1fbe0/openhrt-2020-001564f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5077/8094333/0ed2c7911568/openhrt-2020-001564f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5077/8094333/ad9e229e7b7b/openhrt-2020-001564f06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5077/8094333/72ca906f1cd1/openhrt-2020-001564f07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5077/8094333/f5eb2adfed74/openhrt-2020-001564f08.jpg

相似文献

1
Transcatheter mitral valve repair: an overview of current and future devices.经导管二尖瓣修复术：现有和未来器械概述。
Open Heart. 2021 Apr;8(1). doi: 10.1136/openhrt-2020-001564.
2
Combined Mitral and Tricuspid Versus Isolated Mitral Valve Transcatheter Edge-to-Edge Repair in Patients With Symptomatic Valve Regurgitation at High Surgical Risk.高手术风险的有症状瓣膜反流患者的二尖瓣和三尖瓣联合瓣 versus 单纯二尖瓣瓣环成形术。
JACC Cardiovasc Interv. 2018 Jun 25;11(12):1142-1151. doi: 10.1016/j.jcin.2018.04.010.
3
Combined Tricuspid and Mitral Versus Isolated Mitral Valve Repair for Severe MR and TR: An Analysis From the TriValve and TRAMI Registries.三尖瓣和二尖瓣联合修复与单纯二尖瓣修复治疗重度 MR 和 TR：来自 TriValve 和 TRAMI 注册研究的分析。
JACC Cardiovasc Interv. 2020 Mar 9;13(5):543-550. doi: 10.1016/j.jcin.2019.10.023. Epub 2020 Jan 15.
4
Current status of transcatheter mitral valve repair therapies - From surgical concepts towards future directions.经导管二尖瓣修复治疗的现状——从外科理念到未来方向
Scand Cardiovasc J. 2016 Oct-Dec;50(5-6):367-376. doi: 10.1080/14017431.2016.1248482. Epub 2016 Nov 6.
5
Randomized Trials Are Needed for Transcatheter Mitral Valve Replacement.需要随机试验来进行经导管二尖瓣置换术。
JACC Cardiovasc Interv. 2021 Sep 27;14(18):2039-2046. doi: 10.1016/j.jcin.2021.06.014.
6
Transcatheter mitral valve interventions: pathophysiological considerations in choosing reconstruction versus transcatheter valve implantation.经导管二尖瓣介入治疗：选择二尖瓣重建术与经导管瓣膜植入术的病理生理学考量
EuroIntervention. 2015 Sep;11 Suppl W:W37-41. doi: 10.4244/EIJV11SWA9.
7
Minimally invasive mitral valve surgery after failed transcatheter mitral valve repair in an intermediate-risk cohort.经导管二尖瓣修复失败后行微创二尖瓣手术治疗中危队列患者。
Interact Cardiovasc Thorac Surg. 2022 Jul 9;35(2). doi: 10.1093/icvts/ivac163.
8
[Mitral valve: When conservative, when surgical, when interventional therapy?].[二尖瓣：何时采取保守治疗，何时进行手术治疗，何时采用介入治疗？]
Dtsch Med Wochenschr. 2022 Aug;147(16):1039-1047. doi: 10.1055/a-1639-9337. Epub 2022 Aug 15.
9
Transcatheter Mitral Valve Repair Versus Transcatheter Mitral Valve Replacement in Patients with Mitral insufficiency.二尖瓣反流患者经导管二尖瓣修复术与经导管二尖瓣置换术的比较
Arch Med Res. 2023 Feb;54(2):145-151. doi: 10.1016/j.arcmed.2022.12.009. Epub 2023 Jan 13.
10
Patient Selection for Mitral Transcatheter Edge-to-Edge Repair.二尖瓣经导管缘对缘修复术的患者选择。
Methodist Debakey Cardiovasc J. 2023 May 16;19(3):26-36. doi: 10.14797/mdcvj.1199. eCollection 2023.

引用本文的文献

1
Functional Mitral Regurgitation and the Role of Transcatheter Repair.功能性二尖瓣反流与经导管修复的作用
Struct Heart. 2024 Jul 31;9(7):100347. doi: 10.1016/j.shj.2024.100347. eCollection 2025 Jul.
2
Impact of Baseline Anteroposterior Mitral Annular Dimensions on Clinical Outcomes after MitraClip for Secondary Mitral Regurgitation.二尖瓣前-后瓣环基线尺寸对二尖瓣反流继发二尖瓣夹合术临床结局的影响
Struct Heart. 2025 Mar 20;9(6):100460. doi: 10.1016/j.shj.2025.100460. eCollection 2025 Jun.
3
Case Report: Concurrent transcatheter aortic and mitral valve replacement for symptomatic concomitant aortic and mitral valve stenoses.

本文引用的文献

1
1-Year Outcomes for Transcatheter Repair in Patients With Mitral Regurgitation From the CLASP Study.CLASP研究中二尖瓣反流患者经导管修复的1年结局
JACC Cardiovasc Interv. 2020 Oct 26;13(20):2344-2357. doi: 10.1016/j.jcin.2020.06.019.
2
Safety and performance of a novel transventricular beating heart mitral valve repair system: 1-year outcomes.新型经心室跳动心脏二尖瓣修复系统的安全性和性能：1年随访结果
Eur J Cardiothorac Surg. 2021 Jan 4;59(1):199-206. doi: 10.1093/ejcts/ezaa256.
3
Transcatheter reshaping of the mitral annulus in patients with functional mitral regurgitation: one-year outcomes of the MAVERIC trial.
病例报告：经导管同期主动脉瓣和二尖瓣置换术治疗有症状的主动脉瓣和二尖瓣联合狭窄。
Front Cardiovasc Med. 2024 Dec 9;11:1487061. doi: 10.3389/fcvm.2024.1487061. eCollection 2024.
4
Heart Failure and Secondary Mitral Regurgitation: A Contemporary Review.心力衰竭与继发性二尖瓣反流：当代综述
J Soc Cardiovasc Angiogr Interv. 2023 Dec 4;2(6Part B):101195. doi: 10.1016/j.jscai.2023.101195. eCollection 2023 Nov-Dec.
5
Transcatheter Treatment Options for Functional Mitral Regurgitation: Which Device for Which Patients?功能性二尖瓣反流的经导管治疗选择：哪些患者适合哪种器械？
Interv Cardiol. 2024 Jul 3;19:e10. doi: 10.15420/icr.2021.29. eCollection 2024.
6
Transcatheter Mitral Valve Repair for Failed Surgical Mitral Valve Repair: A Systematic Review and Meta-Analysis.经导管二尖瓣修复术治疗外科二尖瓣修复失败：一项系统评价和荟萃分析。
Rev Cardiovasc Med. 2022 Sep 28;23(10):332. doi: 10.31083/j.rcm2310332. eCollection 2022 Oct.
7
Update on Percutaneous Treatment for HFrEF: A Great Armamentarium for a Poor Ventricular Function.射血分数降低的心力衰竭的经皮治疗进展：针对不良心室功能的强大武器库。
Rev Cardiovasc Med. 2023 Apr 26;24(5):128. doi: 10.31083/j.rcm2405128. eCollection 2023 May.
8
Management options of valvular heart diseases after heart transplantation: A scoping review.心脏移植后瓣膜性心脏病的管理选择：一项范围综述。
Turk Gogus Kalp Damar Cerrahisi Derg. 2024 Jan 29;32(1):112-122. doi: 10.5606/tgkdc.dergisi.2024.25631. eCollection 2024 Jan.
9
Pharmacological Considerations during Percutaneous Treatment of Heart Failure.心力衰竭经皮治疗的药理学考虑。
Curr Pharm Des. 2024;30(8):565-577. doi: 10.2174/0113816128284131240209113009.
10
Outcomes of COMBO therapy for severe mitral regurgitation compared with transcatheter edge-to-edge repair.与经导管缘对缘修复术相比，重度二尖瓣反流的联合治疗效果。
Front Cardiovasc Med. 2024 Feb 26;11:1223588. doi: 10.3389/fcvm.2024.1223588. eCollection 2024.
经导管二尖瓣环成形术治疗功能性二尖瓣反流患者：MAVERIC 试验一年结果。
EuroIntervention. 2021 Jan 20;16(13):1106-1113. doi: 10.4244/EIJ-D-20-00484.
4
Long-Term Survival Following Transcatheter Mitral Valve Repair: Pooled Analysis of Prospective Trials with the Carillon Device.经导管二尖瓣修复术后的长期生存：Carillon 装置前瞻性试验的汇总分析。
Cardiovasc Revasc Med. 2020 Jun;21(6):712-716. doi: 10.1016/j.carrev.2020.02.012. Epub 2020 Feb 25.
5
The REDUCE FMR Trial: A Randomized Sham-Controlled Study of Percutaneous Mitral Annuloplasty in Functional Mitral Regurgitation.REDUCE FMR 试验：经皮二尖瓣成形术治疗功能性二尖瓣反流的随机假手术对照研究。
JACC Heart Fail. 2019 Nov;7(11):945-955. doi: 10.1016/j.jchf.2019.06.011. Epub 2019 Sep 11.
6
Percutaneous repair or medical treatment for secondary mitral regurgitation: outcomes at 2 years.经皮修复或药物治疗二尖瓣关闭不全的 2 年结果。
Eur J Heart Fail. 2019 Dec;21(12):1619-1627. doi: 10.1002/ejhf.1616. Epub 2019 Nov 18.
7
Transcatheter Valve Repair for Patients With Mitral Regurgitation: 30-Day Results of the CLASP Study.经导管二尖瓣修复术治疗二尖瓣反流患者：CLASP 研究的 30 天结果。
JACC Cardiovasc Interv. 2019 Jul 22;12(14):1369-1378. doi: 10.1016/j.jcin.2019.04.034. Epub 2019 Jun 26.
8
Transcatheter Mitral Valve Direct Annuloplasty with the Millipede IRIS Ring.使用千足虫IRIS环进行经导管二尖瓣直接瓣环成形术
Interv Cardiol Clin. 2019 Jul;8(3):261-267. doi: 10.1016/j.iccl.2019.02.001. Epub 2019 Apr 8.
9
Transapical NeoChord mitral valve repair.经心尖NeoChord二尖瓣修复术。
Ann Cardiothorac Surg. 2018 Nov;7(6):812-820. doi: 10.21037/acs.2018.11.04.
10
Early experience with Millipede IRIS transcatheter mitral annuloplasty.千足虫IRIS经导管二尖瓣环成形术的早期经验。
Ann Cardiothorac Surg. 2018 Nov;7(6):780-786. doi: 10.21037/acs.2018.10.05.